Bristol Myers Squibb Co. (BMY)
56.55
-0.40
(-0.70%)
USD |
NYSE |
May 06, 16:00
56.51
-0.04
(-0.07%)
After-Hours: 18:46
Bristol Myers Squibb EPS Diluted (Quarterly) : 1.308 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.742 |
| Johnson & Johnson | 2.141 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.678B |
| Revenue (Quarterly) | 11.49B |
| Total Expenses (Quarterly) | 8.812B |
| Enterprise Value | 152.27B |
| Gross Profit Margin (Quarterly) | 66.29% |
| Profit Margin (Quarterly) | 23.31% |
| Earnings Yield | 6.30% |
| Operating Earnings Yield | 13.30% |
| Normalized Earnings Yield | 10.34 |